Specifications include, but are not limited to: UCLA’s David Geffen School of Medicine (DGSOM) proposes to build a 14,000 GSF Human Gene & Cell Therapy Facility (HGCTF) on Level B of the Center for Health Sciences (CHS) based on an existing program and conceptual plan and will be partially funded by a National Institutes of Health (NIH) C06 grant awarded in 2020. The main space type of the facility is Good Manufacturing Practices (GMP) space, consisting of a series of individual lab rooms dedicated solely to production of biological products for human administration. Strict environmental controls, with HEPA-filtered air, proper air pressure gradients, and humidity control, are required. The footprint of the proposed HGCTF facility falls within the boundaries of the former (decommissioned) hospital’s operating and recovery rooms which have undergone partial/asneeded demolition and abatement in recent seismic upgrade projects. The existing floor height is 13’-6”
